Recombinant Mouse Flt-3 Ligand/FLT3L Protein, CF 427-FL-005/CF from R&D Systems, a Bio-Techne Brand

Product Specs
ItemRecombinant Mouse Flt-3 Ligand/FLT3L Protein, CF
CompanyR&D Systems, a Bio-Techne Brand
Price $189.00Supplier Page View Company Product Page
Catalog Number427-FL-005/CF
SpeciesMouse
FormatLyophilized from a 0.2 µm filtered solution in Acetonitrile and TFA
Molecule NameFlt-3 Ligand/FLT3L
Size5 ug (also 25 ug)
NCBI Full Gene NameFMS-like tyrosine kinase 3 ligand
NCBI Gene AliasesFlt3lg, Ly72L
Purity>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
Molecular WeightObserved: Multiple bands between 18-32 kDa, reducing conditions
Theoretical: 18 kDa
ApplicationsBioactivity
Conjugate/TagUnconjugated
Source/Expression SystemNS0-derived Recombinant Mouse Flt-3 Ligand/FLT3L Protein, CF
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) RNA helicase DDX3X promotes NK cell survival by supporting MCL1 expressionThe Journal of ImmunologyDecember 1, 2025Eshana Mukhopadhyay, Nora Lakes, Durga Krishnamurthy, Jasmine A Tuazon, David E Ohayon, Ayad Ali, Harsha Seelamneni, Lynn H Lee, David A Hildeman, Stephen N Waggonerng/mL IL-7 (#407-ML-005/CF), 100 ng/mL stem cell factor (SCF) (#455-MC-010/CF), and 10 ng/mL Flt-3L (#427-FL-005/CF), all from R&D Systems, for 9 days in a 6-well plate. CRISPR Small guide RNAs (sgRNA) were obtained

(2) Latexin regulates sex dimorphism in hematopoiesis via gender-specific differential expression of microRNA 98-3p and thrombospondin 1Cell reportsMarch 28, 2023Cui X, Zhang C, Wang F, Zhao X, Wang S, Liu J, He D, Wang C, Yang FC, Tong S, et al.

(3) Glycosyltransferase Extl1 promotes CCR7-mediated dendritic cell migration to restrain infection and autoimmunityCell reportsJanuary 31, 2023Liu J, Cheng Y, Zhang X, Chen Y, Zhu H, Chen K, Liu S, Li Z, Cao X.

(4) IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemiaEMBO molecular medicineJanuary 11, 2023Liu X, Sato N, Yabushita T, Li J, Jia Y, Tamura M, Asada S, Fujino T, Fukushima T, Yonezawa T, et al.

(5) BAP1 shapes the bone marrow niche for lymphopoiesis by fine-tuning epigenetic profiles in endosteal mesenchymal stromal cellsCell death and differentiationNovember 1, 2022Jeong J, Jung I, Kim JH, Jeon S, Hyeon DY, Min H, Kang B, Nah J, Hwang D, Um SJ, et al.

(6) Competitive inhibition of IL-2/IL-2R has a dual effect on HSC ex vivo expansion and IL-2R (CD25) contentInternational immunopharmacologySeptember 1, 2022Uslu M, Albayrak E, Kocabaş F.

(7) MDS cells impair osteolineage differentiation of MSCs via extracellular vesicles to suppress normal hematopoiesisCell reportsMay 10, 2022Hayashi Y, Kawabata KC, Tanaka Y, Uehara Y, Mabuchi Y, Murakami K, Nishiyama A, Kiryu S, Yoshioka Y, Ota Y, et al.

(8) The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decisionLeukemiaOctober 1, 2021Herbst F, Lang TJL, Eckert ESP, Wünsche P, Wurm AA, Kindinger T, Laaber K, Hemmati S, Hotz-Wagenblatt A, Zavidij O, et al.

(9) A histone modifier, ASXL1, interacts with NONO and is involved in paraspeckle formation in hematopoietic cellsCell reportsAugust 24, 2021Yamamoto K, Goyama S, Asada S, Fujino T, Yonezawa T, Sato N, Takeda R, Tsuchiya A, Fukuyama T, Tanaka Y, et al.

(10) GLT1 gene delivery based on bone marrow-derived cells ameliorates motor function and survival in a mouse model of ALSScientific reportsJune 17, 2021Ohashi N, Terashima T, Katagi M, Nakae Y, Okano J, Suzuki Y, Kojima H.

(11) The murine DCs transfected with DNA-plasmid encoding CCR9 demonstrate the increased migration to CCL25 and thymic cells in vitro and to the thymus in vivoCytokineJune 1, 2021Tereshchenko V, Bulygin A, Zavodskii R, Maksyutov A, Kurilin V, Fisher M, Semenyuk N, Aladev S, Sennikov S.

(12) Declined miR-181a-5p expression is associated with impaired natural killer cell development and function with agingAging cellMay 1, 2021Lu J, Li S, Li X, Zhao W, Duan X, Gu X, Xu J, Yu B, Sigal LJ, Dong Z, et al.

(13) The E protein-TCF1 axis controls γδ T cell development and effector fateCell reportsFebruary 2, 2021Fahl SP, Contreras AV, Verma A, Qiu X, Harly C, Radtke F, Zúñiga-Pflücker JC, Murre C, Xue HH, Sen JM, et al.

(14) Stem cell transplantation uncovers TDO-AHR regulation of lung dendritic cells in herpesvirus-induced pathologyJCI insightJanuary 25, 2021Gurczynski SJ, Pereira NL, Hrycaj SM, Wilke C, Zemans RL, Moore BB.

(15) Environmental signals rather than layered ontogeny imprint the function of type 2 conventional dendritic cells in young and adult miceNature communicationsJanuary 19, 2021Papaioannou NE, Salei N, Rambichler S, Ravi K, Popovic J, Küntzel V, Lehmann CHK, Fiancette R, Salvermoser J, Gajdasik DW, et al.

(16) Ex Vivo Gene Therapy Treats Bone Complications of Mucopolysaccharidosis Type II Mouse Models through Bone Remodeling ReactivationMolecular therapy. Methods & clinical developmentDecember 11, 2020Wada M, Shimada Y, Iizuka S, Ishii N, Hiraki H, Tachibana T, Maeda K, Saito M, Arakawa S, Ishimoto T, et al.

(17) Authentication of Primary Murine Cell Lines by a Microfluidics-Based Lab-On-Chip SystemBiomedicinesDecember 9, 2020Hong Y, Singh N, Bamopoulos S, Gjerga E, Schmalbrock LK, Balabanian K, Schick M, Keller U, Wirth M.

(18) In Vivo Pre-Instructed HSCs Robustly Execute Asymmetric Cell Divisions In VitroInternational journal of molecular sciencesNovember 3, 2020Girotra M, Trachsel V, Roch A, Lutolf MP.

(19) A novel approach to genetic engineering of T-cell subsets by hematopoietic stem cell infection with a bicistronic lentivirusScientific reportsAugust 13, 2020Bogert NV, Furkel J, Din S, Braren I, Eckstein V, Müller JA, Uhlmann L, Katus HA, Konstandin MH.

(20) Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCIDMolecular therapy. Methods & clinical developmentJune 12, 2020Garcia-Perez L, van Eggermond M, van Roon L, Vloemans SA, Cordes M, Schambach A, Rothe M, Berghuis D, Lagresle-Peyrou C, Cavazzana M, et al.

Be the First to Write a Review!

Flt-3 Ligand/FLT3L Protein

Flt-3 Ligand/FLT3L Protein

Flt-3 Ligand/FLT3L Protein

Flt-3 Ligand/FLT3L Protein

Flt-3 Ligand/FLT3L Protein

Recombinant Mouse Flt-3 Ligand/FLT3L Protein, CF from R&D Systems, a Bio-Techne Brand

R&D Systems, a Bio-Techne Brand

Citations (89)

Reviews

Recombinant Mouse Flt-3 Ligand/FLT3L Protein, CF from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map